Stay updated on Pembrolizumab Entinostat Efficacy in Eye Melanoma Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Entinostat Efficacy in Eye Melanoma Clinical Trial page.

Latest updates to the Pembrolizumab Entinostat Efficacy in Eye Melanoma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedRecruitment status note 'No longer looking for participants' was added, along with new navigation and help sections (How to Read a Study Record, Common Questions, How to Join a Study) and an 'Intervention/Treatment' heading; the revision tag changed from Revision: v3.5.5 to v3.6.0 and the 'Intervention / Treatment' heading formatting was removed.SummaryDifference0.5%

- Check16 days agoChange DetectedThe page revision tag was updated from v3.5.4 to v3.5.5, reflecting a small maintenance update to the page without changing study content.SummaryDifference0.1%

- Check30 days agoChange DetectedThe page shows a new revision tag, updating from v3.5.3 to v3.5.4, indicating a minor system update. The update does not alter the study details, eligibility criteria, or results presented on the page.SummaryDifference0.1%

- Check51 days agoChange DetectedThe page now shows a revision tag v3.5.3, with the v3.5.2 tag removed. This reflects a deployment-level update to the page rather than a substantive content change.SummaryDifference0.1%

- Check58 days agoChange DetectedUpdated the page footer revision indicator from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check87 days agoChange DetectedRevision: v3.5.0 has been added and Revision: v3.4.3 has been removed.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab Entinostat Efficacy in Eye Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Entinostat Efficacy in Eye Melanoma Clinical Trial page.